Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Duration of Androgen Deprivation Therapy in High-Risk Prostate Cancer: A Randomized Phase III TrialEur Urol 2018 Jul 03;[EPub Ahead of Print], A Nabid, N Carrier, AG Martin, JP Bahary, C Lemaire, S Vass, B Bahoric, R Archambault, F Vincent, R Bettahar, M Duclos, MP Garant, L Souhami
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.